-
Study aim
-
Comparison of the efficacy of pain relief in bupivacaine injection through chest tube and intercostal blockage on improvement of ABG indices, pain and need for intravenous analgesic in traumatic patients with rib fracture
-
Design
-
A clinical trial without the control group, with the parallel groups, no blinding, randomized
-
Settings and conduct
-
This not blind, randomized clinical trial will be performed at Kashani and Al-zahra hospitals in Isfahan. In this study 32 traumatic patients with rib fracture will be enrolled and randomly divided into two parallel groups. Then the blood factors including heart rate, HCO3, PO2, PCO2 of patients are recorded before the intervention and every 0.5 hours to 4 hours after the intervention. Pain scores were recorded before the intervention and every 10 minutes to 4 hours after the intervention.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: trauma patients with rib fractures, abnormalities in ABG, consent to participate in the study, the presence of pentothorax and hemothorax. Exclusion criteria: need for intubation, sensitivity to bupivacaine, unstable conditions, need for further action, drug abuse, blood pressure less than 90/60 mmHg or greater than 180/110 mmHg.
-
Intervention groups
-
Intervention group 1: patients undergo intercostal blockage by the standard method with bupivacaine 0.5% as 0.1 ml/kg body weight. Intervention group 2: patients receive chest tube and 20 ml of bupivacaine 0.5% via chest tube Into the pleural space. All patients are given a single dose of the drug. Patients are monitored for up to 12 hours for the severity of pain and the need for opioids.
-
Main outcome variables
-
Narcotic dosage; Pain score; Bicarbonate (HCO3); pH; Pressure of O2 (PO2); Pressure of CO2 (PCO2)